Axys Pharmaceuticals, Inc. (Nasdaq: AXPH), is a drug discovery and development company with a proprietary focus in oncology. Axys is building shareholder value through (1) a broad and diversified pipeline of research and development programs partnered with world-class pharmaceutical companies; (2) expansion of a non-partnered research and development franchise in oncology; and (3) the spin out of affiliated businesses that leverage the company's technologies in order to provide capital for Axys' drug discovery and development programs.

Axys' technology-leveraging businesses are: Axys Advanced Technologies, Inc., a wholly owned combinatorial chemistry oriented company; PPGx, Inc., a majority owned pharmacogenomics company; and Akkadix Corporation (formerly Xyris), an agricultural biotechnology company.

From genetics and genomics research all the way through clinical testing, Axys is redefining the science of drug discovery. Along the way, Axys is developing a broad portfolio of assets to complement its overall strategy, including patents on key disease targets, proprietary software and biochemistry technology and, most importantly, new therapeutic candidates.

The success of Axys' drug discovery platform and business strategy are illustrated by the company's broad pipeline of therapeutics and its strategic collaborations with many of the world's leading pharmaceutical companies. These collaborations, which fund many of the company's basic research programs, provide Axys with a variety of opportunities to commercialize therapeutic products which span a broad range of major diseases, including cardiovascular and respiratory disease, osteoporosis, and autoimmune disorders. Axys is also applying the technology platform for its own benefit, building a proprietary focus in the area of cancer therapeutics.

In addition to its collaborative and proprietary drug discovery efforts, Axys is leveraging its technology base in the areas of agricultural biotechnology, pharmacogenomics, and combinatorial chemistry.

Please explore this section of the Web site to learn more about Axys business strategy and long-term goals.